World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
47
Citations
8335
World Ranking
4793
National Ranking
155

Gabriella Scarlatti publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Gabriella Scarlatti sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 188 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Gabriella Scarlatti D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Gabriella Scarlatti sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Gabriella Scarlatti is affiliated with Vita-Salute San Raffaele University in Italy and has a research profile centered predominantly on medicine, immunology, and microbiology. Their work includes a substantial focus on infectious diseases, virology, immunology, molecular biology, and radiology, nuclear medicine, and imaging.

Scarlatti's contributions cover several critical topics in biomedical research, including HIV research and treatment, SARS-CoV-2 and COVID-19 studies, monoclonal and polyclonal antibodies research, and immune cell function and interaction. They have also examined long-term effects of COVID-19 and interventions in HIV/AIDS research.

Recent papers authored or co-authored by Scarlatti include:

  • Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival (2021, Nature Communications)
  • COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain (2020, Journal of Clinical Investigation)
  • Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions (2021, The Lancet)
  • Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia (2021, The Journal of Clinical Endocrinology & Metabolism)
  • Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers (2021, npj Vaccines)

Frequent coauthors collaborating with Scarlatti include:

  • Monica Tolazzi
  • Stefania Dispinseri
  • Robin J. Shattock
  • Vito Lampasona
  • Ilaria Marzinotto

Several venues regularly publishing Scarlatti's research highlight their active participation in immunology and vaccine science. These include Frontiers in Immunology, npj Vaccines, bioRxiv (Cold Spring Harbor Laboratory), EBioMedicine, and Vaccines.

Scarlatti has also contributed to book publications, such as the volume titled Fc-Mediated Antibody Functions and Fc-Receptor Polymorphism Volume II, published by Frontiers Media in 2023.

Best Publications

  • In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

    Gabriella Scarlatti;Eleonora Tresoldi;Åsa Björndal;Robert Fredriksson

  • Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

    Åsa Björndal;Hongkui Deng;Marianne Jansson;José R. Fiore

  • Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.

    Stefania Dispinseri;Massimiliano Secchi;Massimiliano Secchi;Maria Franca Pirillo;Monica Tolazzi

  • Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: Correlation with Neutralizing Antibodies against Primary Isolates

    Gabriella Scarlatti;Jan Albert;Paolo Rossi;Vida Hodara

  • A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load.

    Mauro S Malnati;Gabriella Scarlatti;Francesca Gatto;Francesca Salvatori

  • Paediatric HIV infection

    Gabriella Scarlatti

  • C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells

    Alessia Verani;Gabriella Scarlatti;Manola Comar;Eleonora Tresoldi

  • Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.

    G Scarlatti;T Leitner;E Halapi;J Wahlberg

  • Analysis of heterogeneous viral populations by direct DNA sequencing

    T Leitner;E Halapi;G Scarlatti;P Rossi

  • Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

    Victoria R. Polonis;Bruce K. Brown;Andrew Rosa Borges;Susan Zolla-Pazner

  • Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay

    Virginie Trouplin;Francesca Salvatori;Fanny Cappello;Veronique Obry

  • Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele

    Lucinda Furci;Gabriella Scarlatti;Samuele Burastero;Giuseppe Tambussi

  • Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.

    Gabriella Scarlatti;Vida Hodara;Paolo Rossi;Luisa Muggiasca

  • Cell-to-Cell Contact Results in a Selective Translocation of Maternal Human Immunodeficiency Virus Type 1 Quasispecies across a Trophoblastic Barrier by both Transcytosis and Infection

    S. Lagaye;M. Derrien;M. Derrien;E. Menu;E. Menu;C. Coïto

  • International network for comparison of HIV neutralization assays: the NeutNet report.

    Eva Maria Fenyö;Alan Heath;Stefania Dispinseri;Harvey Holmes

  • Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence.

    Kwinten Sliepen;Byung Woo Han;Byung Woo Han;Ilja Bontjer;Petra Mooij

  • Cutting Edge: CXCR4 Is a Functional Coreceptor for Infection of Human Macrophages by CXCR4-Dependent Primary HIV-1 Isolates

    Alessia Verani;Elena Pesenti;Simona Polo;Eleonora Tresoldi

  • Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.

    Farideh Sabri;Eleonora Tresoldi;Mariantonietta Di Stefano;Mariantonietta Di Stefano;Simona Polo

  • Cryptic Nature of a Conserved, CD4-Inducible V3 Loop Neutralization Epitope in the Native Envelope Glycoprotein Oligomer of CCR5-Restricted, but Not CXCR4-Using, Primary Human Immunodeficiency Virus Type 1 Strains

    Paolo Lusso;Patricia L. Earl;Francesca Sironi;Fabio Santoro

  • Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.

    E. Björling;G. Scarlatti;A. Von Gegerfelt;J. Albert

Frequent Co-Authors

Paolo Rossi
Paolo Rossi University of Rome Tor Vergata
Eva Maria Fenyö
Eva Maria Fenyö Lund University
Jan Albert
Jan Albert Karolinska Institute
Mauro S. Malnati
Mauro S. Malnati Vita-Salute San Raffaele University
Britta Wahren
Britta Wahren Karolinska Institute
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Anders Fomsgaard
Anders Fomsgaard Statens Serum Institut
Hanneke Schuitemaker
Hanneke Schuitemaker Valneva (Austria)
David C. Montefiori
David C. Montefiori Duke University
Lucia Lopalco
Lucia Lopalco Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online degrees and career options. For those interested in the medical field but seeking flexibility, exploring what medical degree can I get online is a great starting point. Several programs offer online learning that complements a microbiology background.

Public health is a natural extension for microbiology graduates. Finding easy mph online programs can help students quickly enhance their qualifications while balancing other commitments. These programs often focus on epidemiology, infectious diseases, and health policy.

Additionally, combining microbiology with specialized roles like a child life specialist can provide unique career opportunities. Learning how to become a child life specialist online allows professionals to support pediatric patients in medical settings through therapeutic techniques.

It's also important to recognize inclusive education pathways. Many of the best associate degrees for felons include options related to the sciences, ensuring opportunities for those with past records to pursue promising careers in microbiology and health sciences.

Best Scientists Citing Gabriella Scarlatti

Trending Scientists

Recently Published Articles